Eighteen studies examined the effect of GLP-1RAs on weight loss, glucose control and mental illness outcomes in adults with a severe mental disorder, such as major depressive disorder, bipolar effective disorder, schizophrenia spectrum disorders, and alcohol use disorder
What they found: Cagrilintide 4.5 mg: 10.8 % weight reduction vs 3.0 % placebo (p 40 % of patients achieved 25 % weight reduction , historically unprecedented Safety profile in line with Phase 2 data Why it matters: REDEFINE 1 confirmed CagriSema as the largest body-weight signal reported in the published incretin literature to date
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
After reconstitution, working solutions are typically held at 28 C within the stability window the lot-specific Certificate of Analysis indicates
Hall, A.G., Review: The role of glutathione in the regulation of apoptosis
In summary, we have strong converging evidence of reduced alcohol use in individuals taking Semaglutide or Tirzepatide